Trials / Sponsors / ATGC Co., Ltd.
ATGC Co., Ltd.
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Study to Compare the Efficacy and Safety of ATGC-110 (Botulinum Toxin) With Xeomin® for the Treatment of Moder Glabellar Frown Lines | Phase 3 | 2022-10-11 |
| Completed | A Comparative Study of Botulinum Neurotoxin Type A in Treatment of Moderate to Severe Glabellar Frown Lines Glabellar Frown Lines | Phase 1 / Phase 2 | 2019-11-01 |